Ligand Pharmaceuticals
LGND
#2784
Rank
NZ$10.74 B
Marketcap
NZ$538.78
Share price
0.07%
Change (1 day)
73.65%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$2.16 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are NZ$2.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.93 B375.31%
2024-12-31NZ$0.19 B44.66%
2023-12-31NZ$0.13 B-47.55%
2022-12-31NZ$0.26 B-62.7%
2021-12-31NZ$0.69 B-22.9%
2020-12-31NZ$0.90 B-16.27%
2019-12-31NZ$1.08 B3.55%
2018-12-31NZ$1.04 B193.62%
2017-12-31NZ$0.35 B6.68%
2016-12-31NZ$0.33 B0.81%
2015-12-31NZ$0.33 B10.82%
2014-12-31NZ$0.29 B344.69%
2013-12-31NZ$67.05 M-29.08%
2012-12-31NZ$94.54 M-34.35%
2011-12-31NZ$0.14 B38.18%
2010-12-31NZ$0.10 B-45.17%
2009-12-31NZ$0.19 B-39.33%
2008-12-31NZ$0.31 B66.47%
2007-12-31NZ$0.18 B-55.61%
2006-12-31NZ$0.42 B-31.82%
2005-12-31NZ$0.62 B8.81%
2004-12-31NZ$0.57 B5.66%
2003-12-31NZ$0.54 B40.54%
2002-12-31NZ$0.38 B-8.86%
2001-12-31NZ$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$206.45 B 9,428.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$205.65 B 9,391.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$192.78 B 8,797.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$149.29 B 6,790.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$24.20 B 1,017.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$156.17 B 7,107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$116.15 B 5,260.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$105.00 B 4,746.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$0.14 B-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA